Sophisticated and simple
Understanding the Stakes: Sir John Bell’s Warning Sir John Bell, a prominent figure in the UK’s biotechnology sector, has raised significant concerns over the pharmaceutical…
Introduction Recent news of Merck’s decision to scrap its £1 billion research center in King’s Cross, London, has raised alarms about the future of pharmaceutical…
Zentiva’s Major Transition in Ownership Zentiva, the largest producer of generic medicines in Romania, is undergoing a significant change in ownership. The Czech pharmaceutical group…
Overview of Merck’s Decision In a significant blow to the UK’s pharmaceutical sector, Merck, the American multinational pharmaceutical company, has officially announced the cancellation of…